Publications by authors named "Maike Reith"

Claim this Profile
T
Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies.
Nikolaus B Wagner, Benjamin Weide, Mirko Gries, Maike Reith, Kathrin Tarnanidis

J Immunother Cancer· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melanoma-Derived iPCCs Show Differential Tumorigenicity and Therapy Response.
Mathias Bernhardt, Daniel Novak, Yassen Assenov, Elias Orouji, Nathalie Knappe, Maike Reith

Stem Cell Reports· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Directed Dedifferentiation Using Partial Reprogramming Induces Invasive Phenotype in Melanoma Cells.
Nathalie Knappe, Daniel Novak, Kasia Weina, Mathias Bernhardt, Maike Reith

Stem Cells· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diminished levels of the soluble form of RAGE are related to poor survival in malignant melanoma.
Nikolaus B Wagner, Benjamin Weide, Maike Reith, Kathrin Tarnanidis, Coretta Kehrel

Int J Cancer· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab.
Christoffer Gebhardt, Alexandra Sevko, Huanhuan Jiang, Ramtin Lichtenberger, Maike Reith

Clin Cancer Res· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of human B-cell development into plasmablasts by histone deacetylase inhibitor valproic acid.
Anne-Kathrin Kienzler, Marta Rizzi, Maike Reith, Stephen L Nutt, Hermann Eibel

J Allergy Clin Immunol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis